PDL BioPharma Completes Divestiture of the Noden Pharmaceutical Business to Stanley Capital
INCLINE VILLAGE, Nev., Sept. 9, 2020 |PRNewswire| -- PDL BioPharma, Inc. ("PDL" or the "Company") (Nasdaq: PDLI) announces the closing of the sale of its wholly owned subsidiaries Noden Pharma DAC and Noden Pharma USA (collectively "Noden") to Stanley Capital. The total value of the…
PDL BioPharma Completes Divestiture of the Noden Pharmaceutical Business to Stanley Capital
INCLINE VILLAGE, Nev., Sept. 9, 2020 |PRNewswire| -- PDL BioPharma, Inc. ("PDL" or the "Company") (Nasdaq: PDLI) announces the closing of the sale of its wholly owned subsidiaries Noden Pharma DAC and Noden Pharma USA (collectively "Noden") to Stanley Capital. The total value of the…